NL-OMON40571已完成不适用
Investigation of the applicability of dry powder inhalation in children with cystic fibrosis - Dry powder inhalation in children with CF
Rijksuniversiteit Groningen0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •- A physician*s diagnosis of CF
- •- 4 to 14 years of age
- •- Informed consent from the parent(s)/guardian(s)
- •- Assent from the child (informed consent when >=12 years of age)
排除标准
- •No exclusion criteria are formulated.
研究者
相似试验
已完成
不适用
Investigation of the applicability of dry powder inhalation in school childrecystic fibrosis10024970mucoviscidosisNL-OMON37634Rijksuniversiteit Groningen104
已完成
不适用
Investigation of the applicability of dry powder inhalation in patients with Parkinson*s disease.Parkinsons diseaseParkinson10028037NL-OMON38957Rijksuniversiteit Groningen15
已完成
不适用
Dry powder inhalation in patients with Parkinson’s disease.Ability of a Parkinson’s patient to use the inhaler correctly during off periods.NL-OMON24879Department of Pharmaceutical Technology and Biopharmacy, Faculty of Mathematics and Natural Sciences, University of Groningen15
已完成
3 期
A clinical trial to study and compare the effects two dry powder inhaler devices,test and reference, containing salmeterol 25mcg and fluticasone propionate 250mcg with salmeterol 50mcg and fluticasone propionate 500mcg in patients with asthma.CTRI/2008/091/000302Sun Pharma Advanced Research Company Ltd113
尚未招募
不适用
Steroid versus non-steroid medicines in cases of long term pulmonary diseasesCTRI/2018/07/014788Department of Pharmacology